Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Da Hsu

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Disease Markers|March 21, 2014
Clinical significance of survivin expression in patients with urothelial carcinomaHsin-An Chen, Chih-Ming Su, Hsiao-Yen Hsieh, et al.
BMC Complementary and Alternative Medicine|February 26, 2013
The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladderChi-Chen Lu, Mei-Yi Lin, Syue-Yi Chen, et al.
Urology|February 18, 2014
Age-dependent association between Dickkopf-1 and calcium-containing urolithiasisYeong-Chin Jou, Yuh-Shyan Tsai, Hsiao-Yen Hsieh, et al.
Cancer Letters|October 11, 2015
Cyproheptadine exhibits antitumor activity in urothelial carcinoma cells by targeting GSK3β to suppress mTOR and β-catenin signaling pathwaysHsiao-Yen Hsieh, Cheng-Huang Shen, Ru-Inn Lin, et al.
Experimental and Therapeutic Medicine|September 21, 2012
High Dickkopf-1 expression is associated with poor prognosis in patients with advanced urothelial carcinomaCheng-Huang Shen, Hsiao-Yen Hsieh, Yuan-Hung Wang, et al.
Journal of Medical Virology|October 21, 2011
The high incidence of JC virus infection in urothelial carcinoma tissue in TaiwanCheng-Huang Shen, Jiann-Der Wu, Cheng-Da Hsu, et al.
Molecular Medicine (Cambridge, Mass.)|February 3, 2016
Guizhi Fuling Wan as a Novel Agent for Intravesical Treatment for Bladder Cancer in a Mouse ModelChi-Chen Lu, Cheng-Huang Shen, Chia-Bin Chang, et al.
Oncotarget|August 31, 2015
Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinomaChia-Ming Yeh, Pi-Che Chen, Hsiao-Yen Hsieh, et al.
BMC Medical Genomics|May 24, 2011
Distinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urinePi-Che Chen, Ming-Hsuan Tsai, Sidney K H Yip, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Disease Markers|March 21, 2014
Clinical significance of survivin expression in patients with urothelial carcinomaHsin-An Chen, Chih-Ming Su, Hsiao-Yen Hsieh, et al.
BMC Complementary and Alternative Medicine|February 26, 2013
The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladderChi-Chen Lu, Mei-Yi Lin, Syue-Yi Chen, et al.
Urology|February 18, 2014
Age-dependent association between Dickkopf-1 and calcium-containing urolithiasisYeong-Chin Jou, Yuh-Shyan Tsai, Hsiao-Yen Hsieh, et al.
Cancer Letters|October 11, 2015
Cyproheptadine exhibits antitumor activity in urothelial carcinoma cells by targeting GSK3β to suppress mTOR and β-catenin signaling pathwaysHsiao-Yen Hsieh, Cheng-Huang Shen, Ru-Inn Lin, et al.
Experimental and Therapeutic Medicine|September 21, 2012
High Dickkopf-1 expression is associated with poor prognosis in patients with advanced urothelial carcinomaCheng-Huang Shen, Hsiao-Yen Hsieh, Yuan-Hung Wang, et al.
Journal of Medical Virology|October 21, 2011
The high incidence of JC virus infection in urothelial carcinoma tissue in TaiwanCheng-Huang Shen, Jiann-Der Wu, Cheng-Da Hsu, et al.
Molecular Medicine (Cambridge, Mass.)|February 3, 2016
Guizhi Fuling Wan as a Novel Agent for Intravesical Treatment for Bladder Cancer in a Mouse ModelChi-Chen Lu, Cheng-Huang Shen, Chia-Bin Chang, et al.
Oncotarget|August 31, 2015
Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinomaChia-Ming Yeh, Pi-Che Chen, Hsiao-Yen Hsieh, et al.
BMC Medical Genomics|May 24, 2011
Distinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urinePi-Che Chen, Ming-Hsuan Tsai, Sidney K H Yip, et al.
Pageof 2